IDEAS welcomes AstraZeneca to our H2020 project


IDEAS would like to welcome AstraZeneca to our innovative training network as a partner.

Astra Zeneca, are a major research driven pharmaceutical company that has recently established its own statistical innovation group. The IDEAS network and in particular the focus on early drug development is well aligned to the company`s strategy. AstraZeneca will actively engage in the projects of two ESRs which will also include secondments.